These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition. Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830 [TBL] [Abstract][Full Text] [Related]
23. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum. Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927 [TBL] [Abstract][Full Text] [Related]
24. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157 [TBL] [Abstract][Full Text] [Related]
25. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. Sampaio EP; Moreira AL; Sarno EN; Malta AM; Kaplan G J Exp Med; 1992 Jun; 175(6):1729-37. PubMed ID: 1588290 [TBL] [Abstract][Full Text] [Related]
26. Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction. Tadesse A; Abebe M; Bizuneh E; Mulugeta W; Aseffa A; Shannon EJ Immunopharmacol Immunotoxicol; 2006; 28(3):431-41. PubMed ID: 16997792 [TBL] [Abstract][Full Text] [Related]
28. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. Gupta N; Shankernarayan NP; Dharmalingam K J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739 [TBL] [Abstract][Full Text] [Related]
29. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions. Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714 [TBL] [Abstract][Full Text] [Related]
30. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment. Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511 [TBL] [Abstract][Full Text] [Related]
31. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood. Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817 [TBL] [Abstract][Full Text] [Related]
32. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept. Chowdhry S; Shukla A; D'souza P; Dhali T; Jaiswal P Int J Mycobacteriol; 2016 Jun; 5(2):223-5. PubMed ID: 27242236 [TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline downregulates nitric oxide and tumor necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line. Park E; Schuller-Levis G; Park SY; Jia JH; Levis WR Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):225-33. PubMed ID: 11875767 [TBL] [Abstract][Full Text] [Related]
34. Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL. Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MV; Tan EV; Walsh GP Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):61-5. PubMed ID: 9614845 [No Abstract] [Full Text] [Related]
35. The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients. Nath I; Vemuri N; Reddi AL; Jain S; Brooks P; Colston MJ; Misra RS; Ramesh V Immunol Lett; 2000 Dec; 75(1):69-76. PubMed ID: 11163869 [TBL] [Abstract][Full Text] [Related]
36. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation. Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366 [TBL] [Abstract][Full Text] [Related]
37. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum. Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258 [TBL] [Abstract][Full Text] [Related]
38. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Verma KK; Srivastava P; Minz A; Verma K Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003 [TBL] [Abstract][Full Text] [Related]
39. The role of thalidomide in the management of erythema nodosum leprosum. Walker SL; Waters MF; Lockwood DN Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771 [TBL] [Abstract][Full Text] [Related]
40. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum. Dias AA; Silva CO; Santos JP; Batista-Silva LR; Acosta CC; Fontes AN; Pinheiro RO; Lara FA; Machado AM; Nery JA; Sarno EN; Pereira GM; Pessolani MC J Immunol; 2016 Sep; 197(5):1905-13. PubMed ID: 27474073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]